Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.98B Buy
9,092,054
+8,463,716
+1,347% +$1.88B 0.67% 43
2025
Q4
$144M Buy
628,338
+352,487
+128% +$80.3M 0.05% 145
2025
Q3
$63.9M Sell
275,851
-7,729
-3% -$1.57M 0.02% 204
2025
Q2
$52.6M Sell
283,580
-74,056
-21% -$13.8M 0.02% 212
2025
Q1
$74.9M Buy
357,636
+314,403
+727% +$61.1M 0.03% 177
2024
Q4
$7.68M Buy
43,233
+4,319
+11% +$794K ﹤0.01% 460
2024
Q3
$7.68M Sell
38,914
-885
-2% -$165K ﹤0.01% 447
2024
Q2
$6.83M Buy
39,799
+5,876
+17% +$973K ﹤0.01% 462
2024
Q1
$6.18M Buy
33,923
+14
+0% +$2.41K ﹤0.01% 477
2023
Q4
$5.25M Sell
33,909
-3,065
-8% -$447K ﹤0.01% 485
2023
Q3
$5.51M Buy
36,974
+6,562
+22% +$963K ﹤0.01% 511
2023
Q2
$4.1M Buy
30,412
+2,920
+11% +$428K ﹤0.01% 572
2023
Q1
$4.38M Sell
27,492
-2,714
-9% -$415K ﹤0.01% 557
2022
Q4
$4.88M Sell
30,206
-6,303
-17% -$966K ﹤0.01% 536
2022
Q3
$4.9M Buy
36,509
+751
+2% +$108K ﹤0.01% 469
2022
Q2
$5.48M Buy
35,758
+2,108
+6% +$322K ﹤0.01% 418
2022
Q1
$5.46M Sell
33,650
-3,508
-9% -$510K ﹤0.01% 441
2021
Q4
$5.03M Buy
37,158
+1,884
+5% +$223K ﹤0.01% 462
2021
Q3
$3.81M Buy
35,274
+3,460
+11% +$395K ﹤0.01% 459
2021
Q2
$3.58M Buy
31,814
+352
+1% +$39.6K ﹤0.01% 460
2021
Q1
$3.4M Sell
31,462
-1,598
-5% -$171K ﹤0.01% 468
2020
Q4
$3.54M Buy
33,060
+3,380
+11% +$325K ﹤0.01% 455
2020
Q3
$2.6M Sell
29,680
-1,741
-6% -$164K ﹤0.01% 455
2020
Q2
$3.08M Buy
31,421
+2,937
+10% +$259K ﹤0.01% 434
2020
Q1
$2.17M Sell
28,484
-271,252
-90% -$23.1M ﹤0.01% 436
2019
Q4
$26.5M Sell
299,736
-120,362
-29% -$9.99M 0.03% 250
2019
Q3
$31.8M Sell
420,098
-3,778
-0.9% -$259K 0.03% 236
2019
Q2
$30.8M Sell
423,876
-268,584
-39% -$21.1M 0.03% 250
2019
Q1
$55.8M Sell
692,460
-120,616
-15% -$9.87M 0.07% 179
2018
Q4
$75M Sell
813,076
-3,274
-0.4% -$288K 0.1% 139
2018
Q3
$77.2M Buy
816,350
+15,559
+2% +$1.48M 0.09% 152
2018
Q2
$74.2M Buy
800,791
+24,999
+3% +$2.44M 0.1% 149
2018
Q1
$73.4M Buy
775,792
+163,142
+27% +$17.9M 0.1% 150
2017
Q4
$59.2M Sell
612,650
-70,624
-10% -$6.66M 0.08% 187
2017
Q3
$60.7M Sell
683,274
-3,245
-0.5% -$247K 0.09% 173
2017
Q2
$49.8M Buy
686,519
+3,604
+0.5% +$242K 0.08% 191
2017
Q1
$44.5M Sell
682,915
-13,654
-2% -$858K 0.07% 187
2016
Q4
$43.6M Buy
696,569
+12,527
+2% +$765K 0.08% 180
2016
Q3
$43.1M Sell
684,042
-9,352
-1% -$605K 0.08% 172
2016
Q2
$44.6M Sell
693,394
-49,890
-7% -$3.04M 0.08% 163
2016
Q1
$44.2M Sell
743,284
-191,820
-21% -$10.7M 0.08% 155
2015
Q4
$55.4M Buy
935,104
+7,145
+0.8% +$412K 0.11% 137
2015
Q3
$50.5M Sell
927,959
-78,720
-8% -$5.12M 0.11% 136
2015
Q2
$67.6M Sell
1,006,679
-4,077
-0.4% -$266K 0.13% 123
2015
Q1
$59.2M Buy
1,010,756
+9,651
+1% +$583K 0.12% 137
2014
Q4
$65.5M Buy
1,001,105
+1,337
+0.1% +$84.3K 0.14% 129
2014
Q3
$57.7M Sell
999,768
-104,841
-9% -$5.82M 0.12% 125
2014
Q2
$62.3M Buy
1,104,609
+477,470
+76% +$25M 0.13% 123
2014
Q1
$32.2M Sell
627,139
-415,382
-40% -$21M 0.07% 180
2013
Q4
$55.1M Sell
1,042,521
-23,411
-2% -$1.15M 0.12% 136
2013
Q3
$47.7M Sell
1,065,932
-81,185
-7% -$3.6M 0.12% 137
2013
Q2
$47.4M Buy
+1,147,117
New +$50.2M 0.12% 133

Other funds holding ABBV

Ken Fisher's ABBV Position: Q1 2026 in Review

Ken Fisher increased its AbbVie (ABBV) stake by 1,347% in Q1 2026, buying an estimated $1.88B and bringing the position to 9,092,054 shares worth $1.98B. The position accounts for 0.67% of the portfolio, ranked #43.

Ken Fisher first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ken Fisher held 9,092,054 shares of AbbVie worth $1.98B as of Q1 2026.
  • Ken Fisher bought 8,463,716 AbbVie shares in Q1 2026, an estimated $1.88B.
  • AbbVie made up 0.67% of Ken Fisher's portfolio in Q1 2026, its #43 holding.
  • Ken Fisher first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.